Predictors of the failure of treatment with chloroquine plus chlorpheniramine, in children with acute, uncomplicated, Plasmodium falciparum malaria

Abstract Resistance to chloroquine in Plasmodium falciparum can be reversed, both in vitro and in vivo, by chlorpheniramine, a histamine H1 receptor antagonist. This reversal raises the possibility of using chlorpheniramine to prolong the clinical usefulness of chloroquine in resource-poor communities. The factors that identify children at risk of treatment failure after being given chloroquine plus chlorpheniramine have now been evaluated in 281 children with uncomplicated, P. falciparum malaria. The children, who had taken part in six trials of antimalarial drugs between February 1996 and September 1999, in a hyper-endemic area of south-western Nigeria, were enrolled prospectively for the present study. Following treatment with chloroquine plus chlorpheniramine, 13 (5%) of the children failed treatment by day 7 or 14. In a multivariate analysis, an age of ≤3 years (adjusted odds ratio=11.1; 95% confidence interval=2.2−55.3; P=0.003) and a parasitaemia that took >3 days to clear (adjusted odds ratio=7.9; 95% confidence interval= 1.3−49.4; P=0.027) were found to be independent predictors of treatment failure. In addition, compared with the children who had a lower axillary temperature then, the children who had an axillary temperature of ≥38°C 2 days after commencing treatment were significantly more likely to be treatment failures. In resource-poor communities using chloroquine plus chlorpheniramine, the easily identifiable predictors of treatment failure might be used to identify children requiring alternative antimalarial drugs.

[1]  A. Sowunmi,et al.  Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children , 2004, Parasitology.

[2]  S. Satpathy,et al.  Severe falciparum malaria , 2004, Indian journal of pediatrics.

[3]  W. Fawzi,et al.  Age, temperature, and parasitaemia predict chloroquine treatment failure and anaemia in children with uncomplicated Plasmodium falciparum malaria. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[4]  A. Sowunmi A randomized comparison of chloroquine and chloroquine plus ketotifen in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children , 2003, Annals of tropical medicine and parasitology.

[5]  A. Sowunmi,et al.  Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children , 2001 .

[6]  A. Sowunmi,et al.  Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. , 2001, Annals of tropical medicine and parasitology.

[7]  A. Sowunmi,et al.  Comparative Efficacy and Safety of Two Regimens of Chlorpheniramine plus Chloroquine in Acute Uncomplicated Falciparum Malaria in Children , 2000 .

[8]  G. Dorsey,et al.  Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda. , 2000, The American journal of tropical medicine and hygiene.

[9]  A. Sowunmi,et al.  Comparative efficacy of chloroquine plus chlorpheniramine alone and in a sequential combination with sulfadoxine-pyrimethamine, for the treatment of acute, uncomplicated, falciparum malaria in children. , 2000, Annals of tropical medicine and parasitology.

[10]  R. Price,et al.  Risk factors for gametocyte carriage in uncomplicated falciparum malaria. , 1999, The American journal of tropical medicine and hygiene.

[11]  A. Sowunmi,et al.  Comparative efficacy of chloroquine plus chlorpheniramine and halofantrine in acute uncomplicated falciparum malaria in Nigerian children. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[12]  L. Gerena,et al.  In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine. , 1998, The American journal of tropical medicine and hygiene.

[13]  Salako,et al.  Enhancement of the antimalarial effect of chloroquine by chloropheniramine in vivo , 1998, Tropical medicine & international health : TM & IH.

[14]  A. Sowunmi,et al.  Comparative efficacy of chloroquine plus chlorpheniramine and pyrimethamine/sulfadoxine in acute uncomplicated falciparum malaria in Nigerian children. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[15]  A. Sowunmi,et al.  Comparative efficacy of chloroquine/chlorpheniramine combination and mefloquine for the treatment of chloroquine-resistant Plasmodium falciparum malaria in Nigerian children. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[16]  A. Sowunmi,et al.  Enhanced efficacy of chloroquine-chlorpheniramine combination in acute uncomplicated falciparum malaria in children. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[17]  K. Rieckmann,et al.  Risk factors of chloroquine resistance in Plasmodium falciparum malaria. , 1996, Acta tropica.

[18]  A. Sowunmi,et al.  Leukocyte counts in falciparum malaria in African children from an endemic area. , 1995, African journal of medicine and medical sciences.

[19]  J. Le bras,et al.  In vitro reversal of chloroquine resistance with chlorpheniramine against African isolates of Plasmodium falciparum. , 1994, Japanese journal of medical science & biology.

[20]  A. Sowunmi,et al.  Malaria in Nigeria: a revisit. , 1990, Annals of tropical medicine and parasitology.

[21]  R. Ekong,et al.  ANTIHISTAMINIC DRUGS THAT REVERSE CHLOROQUINE RESISTANCE IN PLASMODIUM FALCIPARUM , 1989, The Lancet.

[22]  J. Philpott,et al.  Severe falciparum malaria. , 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[23]  G. Alván,et al.  The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses. , 1987, British journal of clinical pharmacology.

[24]  G. Alván,et al.  Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria. , 1983, British journal of clinical pharmacology.

[25]  Resistance to Antimalarials Chemotherapy of malaria and resistance to antimalarials. Report of a WHO scientific group. , 1973, World Health Organization technical report series.

[26]  A. Shaper,et al.  Genetic neutropenia in people of African origin. , 1971, Lancet.

[27]  Ezeilo Gc Neutropenia in Africans. , 1971 .

[28]  G. C. Ezeilo Neutropenia in Africans. , 1971, Tropical and geographical medicine.